This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pigny, P. Articles by Porchet, N. Search for Related Content PubMed PubMed Citation Articles by Pigny, P. Articles by Porchet, N.

A Novel 9-Base Pair Duplication in RET Exon 8 in Familial Medullary Thyroid Carcinoma¹

Laboratoire de Biochimie-Secteur commun de Biologie Moléculaire de l’Hôpital Huriez (P.P., M.C., M.P.B., J.P.K., N.P.), Service d’Endocrinologie & Médecine Interne (C.B., J.L.W.), Service d’Anatomie Pathologique A (M.L.H.), Centre Hospitalier Régional Universitaire, 59037 Lille Cedex; Laboratoire de Génétique Moléculaire, Hôpital Edouard Herriot (S.G., A.C.), F-69437 Lyon Cedex; and Service d’Endocrinologie, Hôpital de Rangueil, Centre Hospitalier Universitaire (P.C.), F-31403 Toulouse Cedex 4, France

Address all correspondence and requests for reprints to: Pascal Pigny, Pharm.D., Ph.D., Laboratoire de Biochimie, Bâtiment USN-A, Clinique Marc Linquette, Centre Hospitalier Régionale Universitaire, F-59037 Lille Cedex, France. E-mail: p-pigny{at}chru-lille.fr

Familial medullary thyroid carcinoma (FMTC) and multiple endocrine neoplasia type 2A syndromes are dominantly inherited diseases caused by activating germline mutations of the RET protooncogene. The majority of these patients carry a germline point mutation affecting one of five cysteine residues encoded by exon 10 (codon 609, 611, 618, or 620) or 11 (codon 634). In a few FMTC families, point mutations involving noncysteine codons in exon 13 (codons 768, 790, and 791), 14 (codon 804), or 15 (codon 891) have been reported. Hirschsprung’s disease is a nonneoplastic disorder associated with RET mutations leading to a loss of function effect. Mutations are identified in 50% of the familial cases and are scattered along the gene. We now report the study of a FMTC family with four affected members and a history of fatal neonatal intestinal obstruction in the sister of the proband. Genetic analysis demonstrated the absence of an usual FMTC mutation and the presence of a germline 9-bp duplication in RET exon 8 in the heterozygous state in all patients with MTC. This new mutation creates an additional cysteine residue in the extracellular cysteine-rich domain of RET. Further studies are warranted to confirm whether this new mutation is causing MTC only or could be associated with Hirschsprung’s disease.

This article has been cited by other articles:

				D. Cordella, M. Muzza, L. Alberti, P. Colombo, P. Travaglini, P. Beck-Peccoz, L. Fugazzola, and L. Persani An in-frame complex germline mutation in the juxtamembrane intracellular domain causing RET activation in familial medullary thyroid carcinoma. Endocr. Relat. Cancer, September 1, 2006; 13(3): 945 - 953. [Abstract] [Full Text] [PDF]

				J. W. B. de Groot, T. P. Links, J. T. M. Plukker, C. J. M. Lips, and R. M. W. Hofstra RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors Endocr. Rev., August 1, 2006; 27(5): 535 - 560. [Abstract] [Full Text] [PDF]

				C. Jimenez, G. Cote, A. Arnold, and R. F. Gagel Should Patients with Apparently Sporadic Pheochromocytomas or Paragangliomas be Screened for Hereditary Syndromes? J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2851 - 2858. [Abstract] [Full Text] [PDF]

				S Jindrichova, J Vcelak, P Vlcek, M Neradilova, J Nemec, and B Bendlova Screening of six risk exons of the RET proto-oncogene in families with medullary thyroid carcinoma in the Czech Republic J. Endocrinol., November 1, 2004; 183(2): 257 - 265. [Abstract] [Full Text] [PDF]

				G. Orgiana, G. Pinna, A. Camedda, V. De Falco, M. Santoro, R. M. Melillo, R. Elisei, C. Romei, S. Lai, C. Carcassi, et al. A New Germline RET Mutation Apparently Devoid of Transforming Activity Serendipitously Discovered in a Patient with Atrophic Autoimmune Thyroiditis and Primary Ovarian Failure J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4810 - 4816. [Abstract] [Full Text] [PDF]

				C. Jimenez, G. T. Dang, P. N. Schultz, A. El-Naggar, S. Shapiro, E. A. Barnes, D. B. Evans, R. Vassilopoulou-Sellin, R. F. Gagel, G. J. Cote, et al. A Novel Point Mutation of the RET Protooncogene Involving the Second Intracellular Tyrosine Kinase Domain in a Family with Medullary Thyroid Carcinoma J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3521 - 3526. [Abstract] [Full Text] [PDF]

				A. M. Alvares Da Silva, R. M. B. Maciel, M. R. Dias Da Silva, S. R. C. Toledo, M. B. De Carvalho, and J. M. Cerutti A Novel Germ-Line Point Mutation in RET Exon 8 (Gly533Cys) in a Large Kindred with Familial Medullary Thyroid Carcinoma J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5438 - 5443. [Abstract] [Full Text] [PDF]

				C Bauters, M-C Vantyghem, E Leteurtre, M-F Odou, C Mouton, N Porchet, J-L Wemeau, C Proye, and P Pigny Hereditary phaeochromocytomas and paragangliomas: a study of five susceptibility genes J. Med. Genet., June 1, 2003; 40(6): e75 - 75. [Full Text] [PDF]

				L. C. Hofbauer, B. Allolio, and W. Arlt Dehydroepiandrosterone Supplementation in Elderly Men: The Role of Estrogens Versus Androgens on the Male Skeleton J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 4009 - 4009. [Full Text] [PDF]

				F Lesueur, M Corbex, J D McKay, J Lima, P Soares, P Griseri, J Burgess, I Ceccherini, S Landolfi, M Papotti, et al. Specific haplotypes of the RET proto-oncogene are over-represented in patients with sporadic papillary thyroid carcinoma J. Med. Genet., April 1, 2002; 39(4): 260 - 265. [Abstract] [Full Text] [PDF]

				P. Niccoli-Sire, A. Murat, V. Rohmer, S. Franc, G. Chabrier, L. Baldet, B. Maes, F. Savagner, S. Giraud, S. Bezieau, et al. Familial Medullary Thyroid Carcinoma with Noncysteine RET Mutations: Phenotype-Genotype Relationship in a Large Series of Patients J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3746 - 3753. [Abstract] [Full Text] [PDF]

				V. Vlaeminck-Guillem, M. D'herbomez, P. Pigny, A. Fayard, C. Bauters, M. Decoulx, and J.-L. Wemeau Pseudohypoparathyroidism Ia and Hypercalcitoninemia J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3091 - 3096. [Abstract] [Full Text] [PDF]

				J. R Hansford and L. M Mulligan Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis J. Med. Genet., November 1, 2000; 37(11): 817 - 827. [Abstract] [Full Text]